Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles

被引:14
|
作者
Ageely, Eman A. [1 ]
Chilamkurthy, Ramadevi [2 ]
Jana, Sunit [3 ]
Abdullahu, Leonora [3 ]
O'Reilly, Daniel [3 ,5 ]
Jensik, Philip J. [4 ]
Damha, Masad J. [3 ]
Gagnon, Keith T. [1 ,2 ]
机构
[1] Southern Illinois Univ, Dept Chem & Biochem, Carbondale, IL 62901 USA
[2] Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA
[3] McGill Univ, Dept Chem, Montreal, PQ, Canada
[4] Southern Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL USA
[5] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA USA
基金
美国国家卫生研究院;
关键词
GENOME-WIDE ANALYSIS; CRISPR-CAS; IN-VIVO; CRYSTAL-STRUCTURE; OFF-TARGET; ACQUIRED-RESISTANCE; STRUCTURAL BASIS; RNA; DNA; DELIVERY;
D O I
10.1038/s41467-021-26989-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
CRISPR-Cas12a is a leading technology for development of model organisms, therapeutics, and diagnostics. These applications could benefit from chemical modifications that stabilize or tune enzyme properties. Here we chemically modify ribonucleotides of the AsCas12a CRISPR RNA 5 ' handle, a pseudoknot structure that mediates binding to Cas12a. Gene editing in human cells required retention of several native RNA residues corresponding to predicted 2 '-hydroxyl contacts. Replacing these RNA residues with a variety of ribose-modified nucleotides revealed 2 '-hydroxyl sensitivity. Modified 5 ' pseudoknots with as little as six out of nineteen RNA residues, with phosphorothioate linkages at remaining RNA positions, yielded heavily modified pseudoknots with robust cell-based editing. High trans activity was usually preserved with cis activity. We show that the 5 ' pseudoknot can tolerate near complete modification when design is guided by structural and chemical compatibility. Rules for modification of the 5 ' pseudoknot should accelerate therapeutic development and be valuable for CRISPR-Cas12a diagnostics. Development of Cas12a for human therapeutics and diagnostics may significantly benefit from, or even require, chemical modification of its guide RNA. Here the authors show that the noncanonical 5 ' pseudoknot structure of the AsCas12a crRNA guide can be heavily modified and still retain very high editing activity in cells and trans cleavage activity in vitro.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells
    Wang, Chengkun
    Xia, Qiong
    Zhang, Qianhe
    Qu, Yuanhao
    Su, Stephen
    Cheng, Jason K. W.
    Hughes, Nicholas W.
    Cong, Le
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [42] Gene targeting in adult organs using in vivo cleavable donor plasmids for CRISPR-Cas9 and CRISPR-Cas12a
    Ishibashi, Riki
    Maki, Ritsuko
    Toyoshima, Fumiko
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [43] A highly efficient in vivo plasmid editing tool based on CRISPR-Cas12a and phage λ Red recombineering
    Yiman Geng
    Haiqin Yan
    Pei Li
    Gaixian Ren
    Xiaopeng Guo
    Peiqi Yin
    Leiliang Zhang
    Zhaohui Qian
    Zhendong Zhao
    Yi-Cheng Sun
    Journal of Genetics and Genomics, 2019, 46 (09) : 452 - 455
  • [44] A highly efficient in vivo plasmid editing tool based on CRISPR-Cas12a and phage λ Red recombineering
    Geng, Yiman
    Yan, Haiqin
    Li, Pei
    Ren, Gaixian
    Guo, Xiaopeng
    Yin, Peiqi
    Zhang, Leiliang
    Qian, Zhaohui
    Zhao, Zhendong
    Sun, Yi-Cheng
    JOURNAL OF GENETICS AND GENOMICS, 2019, 46 (09) : 455 - 458
  • [45] Gene targeting in adult organs using in vivo cleavable donor plasmids for CRISPR-Cas9 and CRISPR-Cas12a
    Riki Ishibashi
    Ritsuko Maki
    Fumiko Toyoshima
    Scientific Reports, 14
  • [46] A far-red light-inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation
    Wang, Xinyi
    Dong, Kaili
    Kong, Deqiang
    Zhou, Yang
    Yin, Jianli
    Cai, Fengfeng
    Wang, Meiyan
    Ye, Haifeng
    SCIENCE ADVANCES, 2021, 7 (50)
  • [47] Comparison of CRISPR/Cas9 and Cas12a for gene editing in Chlamydomonas reinhardtii
    Ferenczi, Aron
    Fellbaum, Matthew
    Chew, Yen Peng
    Kidner, Catherine
    Molnar, Attila
    ALGAL RESEARCH-BIOMASS BIOFUELS AND BIOPRODUCTS, 2024, 84
  • [48] Optimization of Nuclear Localization Signal Composition Improves CRISPR-Cas12a Editing Rates in Human Primary Cells
    Luk, Kevin
    Liu, Pengpeng
    Zeng, Jing
    Wang, Yetao
    Maitland, Stacy A.
    Idrizi, Feston
    Ponnienselvan, Karthikeyan
    Zhu, Lihua Julie
    Luban, Jeremy
    Bauer, Daniel E.
    Wolfe, Scot A.
    GEN BIOTECHNOLOGY, 2022, 1 (03): : 271 - 284
  • [49] An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing
    Duan, Nannan
    Tang, Shuqing
    Zeng, Baitao
    Hu, Zhiqing
    Hu, Qian
    Wu, Lingqian
    Zhou, Miaojin
    Liang, Desheng
    LIFE-BASEL, 2021, 11 (11):
  • [50] A Novel and Efficient Genome Editing Tool Assisted by CRISPR-Cas12a/Cpf1 for Pichia pastoris
    Zhang, Xinying
    Gu, Songjie
    Zheng, Xueyun
    Peng, Siqi
    Li, Yanru
    Lin, Ying
    Liang, Shuli
    ACS SYNTHETIC BIOLOGY, 2021, 10 (11): : 2927 - 2937